Insulet Corporation (PODD)
Return on total capital
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 250,800 | 167,800 | 107,200 | 42,000 | 46,300 | 63,300 | 91,400 | 106,600 | 82,200 | 28,000 | 21,700 | 62,700 | 57,800 | 81,200 | 66,400 | 46,800 | 49,100 | 49,117 | 47,357 | 43,759 |
Long-term debt | US$ in thousands | — | — | 1,368,600 | 1,368,800 | 1,374,300 | 1,379,800 | 1,385,200 | 1,390,500 | 1,248,800 | 1,257,000 | 1,235,200 | 1,051,600 | 1,043,700 | 921,500 | 910,200 | 899,000 | 887,900 | 985,771 | 607,351 | 599,601 |
Total stockholders’ equity | US$ in thousands | 732,700 | 607,500 | 553,900 | 502,800 | 476,400 | 428,000 | 422,400 | 446,700 | 556,300 | 497,900 | 459,100 | 585,300 | 603,600 | 595,000 | 563,300 | 59,000 | 75,900 | 150,600 | 249,800 | 223,600 |
Return on total capital | 34.23% | 27.62% | 5.58% | 2.24% | 2.50% | 3.50% | 5.06% | 5.80% | 4.55% | 1.60% | 1.28% | 3.83% | 3.51% | 5.35% | 4.51% | 4.89% | 5.09% | 4.32% | 5.52% | 5.32% |
December 31, 2023 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $250,800K ÷ ($—K + $732,700K)
= 34.23%
Insulet Corporation's return on total capital has exhibited fluctuations over the past eight quarters. The return on total capital ranged from a low of 1.44% in Q1 2023 to a high of 10.24% in Q4 2023. The company's return on total capital gradually increased from Q1 2022 to Q4 2023, indicating an improving utilization of both equity and debt to generate profit. Despite fluctuations, the trend shows progress towards more efficient capital utilization and potentially enhanced shareholder value.setDescription
Peer comparison
Dec 31, 2023
Company name
Symbol
Return on total capital
Insulet Corporation
PODD
34.23%
3M Company
MMM
-48.86%
Artivion Inc
AORT
0.63%
Baxter International Inc
BAX
37.43%
Becton Dickinson and Company
BDX
4.96%
Boston Scientific Corp
BSX
12.15%
DexCom Inc
DXCM
16.23%
Embecta Corp
EMBC
22.29%
Glaukos Corp
GKOS
-16.13%
Globus Medical
GMED
3.02%
Haemonetics Corporation
HAE
9.38%